Anixa Biosciences Inc Quarterly Common Stock, Shares, Issued from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Anixa Biosciences Inc quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q2 2024.
  • Anixa Biosciences Inc Common Stock, Shares, Issued for the quarter ending July 31, 2024 was 32.1M shares, a 3.64% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 32.1M +1.13M +3.64% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 32M +1.05M +3.38% Apr 30, 2024 10-Q 2024-06-04
Q4 2023 31.8M +832K +2.69% Jan 31, 2024 10-Q 2024-03-12
Q3 2023 31.1M +231K +0.75% Oct 31, 2023 10-Q 2024-09-06
Q2 2023 31M +364K +1.19% Jul 31, 2023 10-Q 2023-09-06
Q1 2023 31M +804K +2.67% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 30.9M +791K +2.62% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 30.9M +863K +2.87% Oct 31, 2022 10-K 2024-01-16
Q2 2022 30.7M +704K +2.35% Jul 31, 2022 10-Q 2022-09-09
Q1 2022 30.2M -1.3M -4.12% Apr 30, 2022 10-Q 2022-06-10
Q4 2021 30.1M +3.95M +15.1% Jan 31, 2022 10-Q 2022-03-11
Q3 2021 30.1M +5.8M +23.9% Oct 31, 2021 10-K 2023-01-04
Q2 2021 29.9M +6.3M +26.6% Jul 31, 2021 10-Q 2021-09-01
Q1 2021 31.4M +9.97M +46.4% Apr 30, 2021 10-Q 2021-06-10
Q4 2020 26.2M +5.34M +25.6% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 24.2M +3.92M +19.3% Oct 31, 2020 10-K 2022-01-04
Q2 2020 23.7M +3.49M +17.3% Jul 31, 2020 10-Q 2020-09-08
Q1 2020 21.5M +1.47M +7.37% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 20.8M +1.37M +7.04% Jan 31, 2020 10-Q 2020-03-09
Q3 2019 20.3M +1.42M +7.53% Oct 31, 2019 10-K 2021-01-07
Q2 2019 20.2M +1.47M +7.85% Jul 31, 2019 10-Q 2019-09-06
Q1 2019 20M +3.15M +18.7% Apr 30, 2019 10-Q 2019-06-12
Q4 2018 19.5M +2.84M +17.1% Jan 31, 2019 10-Q 2019-03-13
Q3 2018 18.9M +2.31M +13.9% Oct 31, 2018 10-K 2020-01-09
Q2 2018 18.7M +3.58M +23.7% Jul 31, 2018 10-Q 2018-09-07
Q1 2018 16.9M +5.16M +44.1% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 16.6M +7.87M +89.9% Jan 31, 2018 10-Q 2018-03-09
Q3 2017 16.6M +7.85M +89.7% Oct 31, 2017 10-K 2019-01-11
Q2 2017 15.1M +6.37M +72.8% Jul 31, 2017 10-Q 2017-09-08
Q1 2017 11.7M +2.96M +33.8% Apr 30, 2017 10-Q 2017-05-26
Q4 2016 8.76M +27.2K +0.31% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 8.75M +27.5K +0.32% Oct 31, 2016 10-K 2018-01-09
Q2 2016 8.75M +26.9K +0.31% Jul 31, 2016 10-Q 2016-08-19
Q1 2016 8.74M -210M -96% Apr 30, 2016 10-Q 2016-05-20
Q4 2015 8.73M -211M -96% Jan 31, 2016 10-Q 2016-02-19
Q3 2015 8.72M -63.3K -0.72% Oct 31, 2015 10-K/A 2016-12-08
Q2 2015 8.72M -228M -96.3% Jul 31, 2015 10-Q 2015-08-18
Q1 2015 219M -490K -0.22% Apr 30, 2015 10-Q 2015-05-22
Q4 2014 220M +9.19M +4.37% Jan 31, 2015 10-Q 2015-03-09
Q3 2014 8.79M -200M -95.8% Oct 31, 2014 10-K 2015-12-23
Q2 2014 237M +30.6M +14.9% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 219M +19.5M +9.77% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 211M +25.4M +13.7% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 209M +24.3M +13.1% Oct 31, 2013 10-K 2015-01-29
Q2 2013 206M +22M +11.9% Jul 31, 2013 10-Q/A 2013-09-20
Q1 2013 200M +18.4M +10.2% Apr 30, 2013 10-Q/A 2013-06-19
Q4 2012 185M +4.65M +2.58% Jan 31, 2013 10-Q/A 2013-03-25
Q3 2012 185M +8.85M +5.02% Oct 31, 2012 10-K/A 2014-01-17
Q2 2012 184M +12M +6.99% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 181M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 180M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 176M +22.4M +14.6% Oct 31, 2011 10-K 2013-01-29
Q2 2011 172M Jul 31, 2011 10-Q/A 2011-10-14
Q3 2010 154M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.